These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Herb-drug interactions: an overview of the clinical evidence. Izzo AA Fundam Clin Pharmacol; 2005 Feb; 19(1):1-16. PubMed ID: 15660956 [TBL] [Abstract][Full Text] [Related]
5. Pyrazolines: a biological review. Marella A; Ali MR; Alam MT; Saha R; Tanwar O; Akhter M; Shaquiquzzaman M; Alam MM Mini Rev Med Chem; 2013 May; 13(6):921-31. PubMed ID: 23544604 [TBL] [Abstract][Full Text] [Related]
6. Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major. Keighobadi M; Emami S; Fakhar M; Shokri A; Mirzaei H; Hosseini Teshnizi S Parasitol Int; 2019 Apr; 69():103-109. PubMed ID: 30582997 [TBL] [Abstract][Full Text] [Related]
7. Management of drug and food interactions with azole antifungal agents in transplant recipients. Dodds-Ashley E Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361 [TBL] [Abstract][Full Text] [Related]
8. The Azoles in Pharmacochemistry: Perspectives on the Synthesis of New Compounds and Chemoinformatic Contributions. de Oliveira Viana J; Monteiro AFM; Filho JMB; Scotti L; Scotti MT Curr Pharm Des; 2019; 25(44):4702-4716. PubMed ID: 31763967 [TBL] [Abstract][Full Text] [Related]
9. Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition. Dvorak Z Toxicol Lett; 2011 Apr; 202(2):129-32. PubMed ID: 21333771 [TBL] [Abstract][Full Text] [Related]
10. New drugs of 1989. Hussar DA Am Pharm; 1990 Mar; NS30(3):27-49. PubMed ID: 2316446 [No Abstract] [Full Text] [Related]
11. Medically important fungi respond to azole drugs: an update. Zavrel M; White TC Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644 [TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions. Lund M; Petersen TS; Dalhoff KP Drugs; 2017 May; 77(8):859-883. PubMed ID: 28382570 [TBL] [Abstract][Full Text] [Related]
13. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy. Emami S; Tavangar P; Keighobadi M Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033 [TBL] [Abstract][Full Text] [Related]
14. In vitro interactions of azoles and echinocandins against clinical strains of Aspergillus flavus. Denardi LB; Oliveira V; de Jesus FPK; Dalla-Lana BH; Santurio JM; Zanette RA; Alves SH Med Mycol; 2018 Nov; 56(8):1006-1011. PubMed ID: 29294129 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Saad AH; DePestel DD; Carver PL Pharmacotherapy; 2006 Dec; 26(12):1730-44. PubMed ID: 17125435 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Brüggemann RJ; Alffenaar JW; Blijlevens NM; Billaud EM; Kosterink JG; Verweij PE; Burger DM Clin Infect Dis; 2009 May; 48(10):1441-58. PubMed ID: 19361301 [TBL] [Abstract][Full Text] [Related]
17. [Present problems and future trend of antifungals for deep seated mycosis. Azole antifungal agents]. Niki Y; Nakajima M; Matsushima T Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):163-8. PubMed ID: 10423511 [TBL] [Abstract][Full Text] [Related]
18. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections. Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882 [TBL] [Abstract][Full Text] [Related]
19. Application of liposomes in medicine and drug delivery. Daraee H; Etemadi A; Kouhi M; Alimirzalu S; Akbarzadeh A Artif Cells Nanomed Biotechnol; 2016; 44(1):381-91. PubMed ID: 25222036 [TBL] [Abstract][Full Text] [Related]